News

Moderna's phase 1 trial of mRNA vaccine against HIV is deigned to enroll 40 patients.

Developers of the drug express disappointment but plan to seek meetings with regulators in hopes of reviving the application.

This opinion piece contributed by Draper voices today's digital platforms can help eliminate the administrative burden on nurses.

The government awarded $80 million in grants to help 60 organizations train more than 1,500 navigators who will focus particularly on underserved communities.

The scientific community has the urgent opportunity to produce more research on the proven health benefits of testosterone and other hormones for women.

The full results from the Emperor-Preserved trial show Jardiance reduces the risk of hospital and death from heart failure.

In this final part of a three-part video series, Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.

Greater uptake of hepatitis C medication may help improve the health of Medicaid enrollees and reduce the economic burden of untreated hepatitis C on the U.S. healthcare system, the authors said.

In this final part of a three-part video series, Managed Healthcare Executive® Managing Editor Peter Wehrwein recently interviewed Kulleni Gebreyes, M.D., director of Deloitte's new Health Equity Institute about her career, healthcare disparities and equity issues and the work of the institute.

The resulting spike in telehealth use exceeded expectations, with an 11,718% increase in remote Medicare visits between March and April 2020.

In this second of a three-part video series, Managed Healthcare Executive® Managing Editor Peter Wehrwein recently interviewed Kulleni Gebreyes, M.D., director of Deloitte's new Health Equity Institute about her career, healthcare disparities and equity issues and the work of the institute.

Tecentriq loses indication, Xarelto is approved for reduce risks of cardiovascular events, Tibsovo is approved for rare cancer, Skytrofa is a new, once-weekly growth hormone, and supplemental application is filed Orencia graft-versus-host disease.

In this first of a three-part video series, Managed Healthcare Executive® Managing Editor Peter Wehrwein recently interviewed Kulleni Gebreyes, M.D., director of Deloitte's new Health Equity Institute about her career, healthcare disparities and equity issues and the work of the institute.

Employees are willing to change jobs to receive better coverage for specialty medications.

Organizations should prepare for massive updates to quality measurement and reimbursement in 2023, while simultaneously addressing cost measurement in 2022.

The update indicates there is a serious risk of dehydration and is contraindicated in children.

Bluebook Rx is a new solution that helps employers and plan sponsors better understand and optimize their prescription drug spending.

In this second part of a three-part video series, Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.

In this first part of a three-part video series, Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.

The new model indicates a small initial impact on new drugs coming to the market, but an impact that grows over time.

Public insurers such as Medicaid, especially in states that expanded coverage under the ACA, kept people insured.

This is the seventh year in a row the program increased savings.

Study results reported in JAMA Network Open show that financial incentives are only modestly effective in getting more people to get way screened for colorectal cancer.

The transition from treating patients at a provider’s site to delivering care in the home and community requires two things: an ability to incorporate social determinants of health into the care coordination process and the inclusion of value-based care and community-based organizations as compensated care delivery partners in VBC networks.

The liquid therapy to treat hypothyroidism now comes in 15 different dosage strengths in single-use packaging.

ICER calculations using real-world data would result in major price cuts of three therapies — Takhzyro, Haegarda, and Cinryze — if they were to meet commonly used cost-effective thresholds.

U.S. Preventive Services Task Force (USPSTF) screening recommendations for diabetes, prediabetes need to be coupled with public health measures, argues accompanying editorial.